Pfizer building’s column scare tests Midtown East’s biggest conversion bet
All eyes were on Midtown East last week after steel columns buckled inside the Pfizer building conversion project, forcing evacuations at the site and nearby buildings on Tuesday. The structural failures at 235 East 42nd Street — where Nathan Berman’s MetroLoft Management and investor David Werner are converting the pharmaceutical firm’s former headquarters into 1,600 apartments — captured national headlines and sparked surprise among industry players, as well as a probe by the city’s Department of Investigation into their cause. Though the building has since been stabilized, its near-collapse — and the spotlight it attracted — also raises questions about […]
This article originally appeared on The Real Deal. Click here to read the full story.
Categories
Recent Posts

Is It Time To Leave New York City? Not So Fast

Growing Appeal Of Mass Timber Attracts Big Tech, Developer
Investment

Why Soft Rents Are The Wrong Reason To Wait On Rental
Property

Choose The Right Platform To Expand Your Real Estate
Brokerage Business

Wildfire Smoke Damage Affects Homeownership Risks And
Costs

A Portland Newspaper Fortune Headlines This $7 Million
Riverfront Estate

The 17th Century Home Of Four Doges Of Venice Finally Comes
To Market

How To Expand Your Commercial Real Estate Brokerage
Business

Residential Developers Dive Into Science Of Blue
Space

Hard To Scale, Impossible To Ignore: Housing
Innovation


